NO20044137L - Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter - Google Patents

Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter

Info

Publication number: NO20044137L
Authority: NO; Norway
Prior art keywords: intermediates; preparation; well; aminoindazole derivatives; aminoindazole
Prior art date: 2002-03-11

Application number

NO20044137A

Other languages

English (en)

Other versions

NO329384B1 (no

Inventor

Gilles Dutruc-Rosset

Dominique Le Suisse

Thomas Rooney

Franck Halley

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-11

Filing date

2004-09-29

Publication date

2004-11-25

2004-09-29 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2004-11-25 Publication of NO20044137L publication Critical patent/NO20044137L/no

2010-10-11 Publication of NO329384B1 publication Critical patent/NO329384B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20044137A 2002-03-11 2004-09-29 Aminoindazolderivater, fremstilling derav samt farmasoytiske preparater og medisinske produkter inneholdende forbindelsene NO329384B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0202997A FR2836915B1 (fr)	2002-03-11	2002-03-11	Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
PCT/FR2003/000752 WO2003078403A2 (fr)	2002-03-11	2003-03-07	Derives d’aminoindazoles comme inhibiteurs de proteine-kinase

Publications (2)

Publication Number	Publication Date
NO20044137L true NO20044137L (no)	2004-11-25
NO329384B1 NO329384B1 (no)	2010-10-11

Family

ID=27763685

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044137A NO329384B1 (no)	2002-03-11	2004-09-29	Aminoindazolderivater, fremstilling derav samt farmasoytiske preparater og medisinske produkter inneholdende forbindelsene

Country Status (30)

Country	Link
US (1)	US6949579B2 (no)
EP (1)	EP1487804B1 (no)
JP (2)	JP4648630B2 (no)
KR (1)	KR101068770B1 (no)
CN (2)	CN1656078A (no)
AR (1)	AR038915A1 (no)
AU (1)	AU2003242809B8 (no)
BR (1)	BR0308373A (no)
CA (1)	CA2478542C (no)
FR (1)	FR2836915B1 (no)
GT (1)	GT200300057A (no)
HR (1)	HRP20040824B1 (no)
IL (2)	IL163831A0 (no)
JO (1)	JO2326B1 (no)
MA (1)	MA27230A1 (no)
ME (2)	ME00058B (no)
MX (1)	MXPA04007478A (no)
MY (1)	MY138269A (no)
NO (1)	NO329384B1 (no)
NZ (1)	NZ535147A (no)
PA (1)	PA8568301A1 (no)
PE (1)	PE20040155A1 (no)
PL (1)	PL370478A1 (no)
RS (1)	RS52396B (no)
RU (1)	RU2345070C2 (no)
SV (1)	SV2003001494A (no)
TW (1)	TWI329103B (no)
UY (1)	UY27713A1 (no)
WO (1)	WO2003078403A2 (no)
ZA (1)	ZA200406687B (no)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2836914B1 (fr) *	2002-03-11	2008-03-14	Aventis Pharma Sa	Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
WO2003097610A1 (en) *	2002-05-17	2003-11-27	Pharmacia Italia S.P.A.	Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP1537087B1 (fr) *	2002-09-05	2012-11-28	Aventis Pharma S.A.	Derives de 3-aminoindazole comme inhibiteurs de kinase et compositions pharmaceutiques les renfermant
MXPA05005794A (es)	2002-12-02	2005-08-16	Hoffmann La Roche	Derivados de indazol como antagonistas del factor de liberacion de corticotropina.
HRP20050533A2 (en) *	2002-12-12	2006-11-30	Aventis Pharma S.A.	Aminoindazole derivatives and use thereof as kinase inhibitors
FR2848554A1 (fr) *	2002-12-12	2004-06-18	Aventis Pharma Sa	Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
US7135575B2 (en)	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
US7994196B2 (en)	2004-02-12	2011-08-09	Mitsubishi Tanabe Pharma Corporation	Indazole compound and pharmaceutical use thereof
FR2871158A1 (fr) *	2004-06-04	2005-12-09	Aventis Pharma Sa	Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
GT200500208A (es)	2004-08-03	2006-03-02		Indazoles ùtiles para tratar enfermedades cardiovasculares
WO2007032936A2 (en) *	2005-09-09	2007-03-22	Schering Corporation	Azafused cyclin dependent kinase inhibitors
JP5131990B2 (ja)	2006-01-31	2013-01-30	アレイバイオファーマ、インコーポレイテッド	キナーゼ阻害剤およびその使用方法
AU2007283113A1 (en)	2006-08-08	2008-02-14	Sanofi-Aventis	Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
EA017852B1 (ru) *	2006-12-20	2013-03-29	НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л.	Производные замещенных индазолов, активные в качестве ингибиторов киназ
DE102007022565A1 (de) *	2007-05-14	2008-11-20	Merck Patent Gmbh	Heterocyclische Indazolderivate
US8299057B2 (en) *	2007-07-20	2012-10-30	Nerviano Medical Sciences S.R.L.	Substituted indazole derivatives active as kinase inhibitors
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN101977905B (zh)	2008-01-23	2014-07-02	百时美施贵宝公司	4-吡啶酮化合物及其对于癌症的用途
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
JP5580332B2 (ja) *	2008-12-18	2014-08-27	ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ	キナーゼ阻害剤として活性な置換インダゾール誘導体
TWI516487B (zh)	2009-04-30	2016-01-11	葛蘭素集團有限公司	新穎化合物、其醫藥組合物及作為激酶活性抑制劑之用途
BR112012003973A2 (pt)	2009-08-26	2015-09-08	Sanofi Sa	hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso
US9180127B2 (en)	2009-12-29	2015-11-10	Dana-Farber Cancer Institute, Inc.	Type II Raf kinase inhibitors
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011115725A2 (en) *	2010-03-16	2011-09-22	Dana-Farber Cancer Institute, Inc.	Indazole compounds and their uses
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
ES2650744T3 (es)	2010-12-14	2018-01-22	Electrophoretics Limited	Inhibidores de la caseína quinasa 1 delta (CK1delta)
WO2012120056A1 (de)	2011-03-08	2012-09-13	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809325B2 (en)	2011-03-08	2014-08-19	Sanofi	Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120053A1 (de)	2011-03-08	2012-09-13	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de)	2011-03-08	2015-04-22	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120050A1 (de)	2011-03-08	2012-09-13	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8895547B2 (en)	2011-03-08	2014-11-25	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683701B1 (de)	2011-03-08	2014-12-24	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
ES2882807T3 (es)	2011-09-16	2021-12-02	Novartis Ag	Heterociclil carboxamidas N-sustituidas
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP3569598A1 (en)	2011-11-17	2019-11-20	Dana Farber Cancer Institute, Inc.	Inhibitors of c-jun-n-terminal kinase (jnk)
WO2013100568A1 (en) *	2011-12-27	2013-07-04	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compounds for use in preventing or treating stroke
EP2909194A1 (en)	2012-10-18	2015-08-26	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 (cdk7)
US9758522B2 (en)	2012-10-19	2017-09-12	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged small molecules as inducers of protein degradation
WO2014063054A1 (en)	2012-10-19	2014-04-24	Dana-Farber Cancer Institute, Inc.	Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
WO2015058126A1 (en)	2013-10-18	2015-04-23	Syros Pharmaceuticals, Inc.	Heteroaromatic compounds useful for the treatment of prolferative diseases
JP6491202B2 (ja)	2013-10-18	2019-03-27	デイナファーバーキャンサーインスティチュート，インコーポレイテッド	サイクリン依存性キナーゼ７（ｃｄｋ７）の多環阻害剤
CN103739550B (zh) *	2014-01-02	2016-06-01	中国药科大学	2,3-二甲基-6-脲-2h-吲唑类化合物及其制备方法与应用
WO2015112445A1 (en) *	2014-01-24	2015-07-30	Abbvie Inc.	6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use
TWI672141B (zh)	2014-02-20	2019-09-21	美商醫科泰生技	投予ｒｏｓ１突變癌細胞之分子
US9862688B2 (en)	2014-04-23	2018-01-09	Dana-Farber Cancer Institute, Inc.	Hydrophobically tagged janus kinase inhibitors and uses thereof
US10017477B2 (en)	2014-04-23	2018-07-10	Dana-Farber Cancer Institute, Inc.	Janus kinase inhibitors and uses thereof
KR101731624B1 (ko) *	2014-07-01	2017-05-04	광주과학기술원	세포 리프로그래밍 유도용 조성물
MY188447A (en) *	2014-08-19	2021-12-09	Shanghai Haihe Pharmaceutical Co Ltd	Indazole compounds as fger kinase inhibitor, preparation and use thereof
KR102595599B1 (ko)	2014-12-02	2023-11-02	이그니타, 인코포레이티드	신경모세포종의 치료를 위한 병용
WO2016096709A1 (en)	2014-12-16	2016-06-23	Eudendron S.R.L.	Heterocyclic derivatives modulating activity of certain protein kinases
HK1245260A1 (zh)	2014-12-23	2018-08-24	Dana-Farber Cancer Institute, Inc.	细胞周期蛋白依赖性激酶7(cdk7)的抑制剂
JP6861166B2 (ja)	2015-03-27	2021-04-21	ダナ−ファーバーキャンサーインスティテュート，インコーポレイテッド	サイクリン依存性キナーゼの阻害剤
CN106279119B (zh) *	2015-05-27	2020-06-16	上海海和药物研究开发有限公司	一种新型激酶抑制剂的制备及其应用
CA2986441A1 (en)	2015-06-12	2016-12-15	Dana-Farber Cancer Institute, Inc.	Combination therapy of transcription inhibitors and kinase inhibitors
GB201511382D0 (en)	2015-06-29	2015-08-12	Imp Innovations Ltd	Novel compounds and their use in therapy
US11142507B2 (en)	2015-09-09	2021-10-12	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinases
BR112018007720A2 (pt) *	2015-10-22	2018-10-23	Selvita S A	novos derivados de piridona e seu uso como inibidores da quinase
CN105467027B (zh) *	2015-11-18	2021-09-21	北京万全德众医药生物技术有限公司	一种用气相色谱法分离测定米诺膦酸中间体有关物质的方法
EP3389645A4 (en)	2015-12-18	2019-12-18	Ignyta, Inc.	COMBINATIONS FOR TREATING CANCER
WO2019018570A1 (en)	2017-07-19	2019-01-24	Ignyta, Inc.	PHARMACEUTICAL COMPOSITIONS CONTAINING ENTRECTINIB
AU2018312349A1 (en)	2017-08-01	2020-02-06	Theravance Biopharma R&D Ip, Llc	Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
JP7311498B2 (ja)	2017-10-17	2023-07-19	イグナイタインコーポレイテッド	薬学的組成物および剤形
CN110117278B (zh) *	2018-02-07	2022-07-19	石家庄以岭药业股份有限公司	烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
EP3810132A4 (en)	2018-06-25	2022-06-22	Dana-Farber Cancer Institute, Inc.	TAIRE FAMILY KINASE INHIBITORS AND RELATED USES
ES2963696T3 (es)	2018-10-24	2024-04-01	Bristol Myers Squibb Co	Compuestos diméricos de indol sustituidos
US12172995B2 (en)	2018-10-24	2024-12-24	Bristol-Myers Squibb Company	Substituted indole and indazole compounds
CA3124422A1 (en)	2018-12-28	2020-07-02	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 and uses thereof
EP3914348A1 (en)	2019-01-23	2021-12-01	Theravance Biopharma R&D IP, LLC	Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors
US12187723B2 (en)	2019-05-09	2025-01-07	Bristol-Myers Squibb Company	Substituted benzimidazolone compounds
EP4041730A1 (en)	2019-10-01	2022-08-17	Bristol-Myers Squibb Company	Substituted bicyclic heteroaryl compounds
WO2021067657A1 (en)	2019-10-04	2021-04-08	Bristol-Myers Squibb Company	Substituted carbazole compounds
JP7788377B2 (ja) *	2019-12-04	2025-12-18	シンジェンタクロッププロテクションアクチェンゲゼルシャフト	殺有害生物的に活性な縮合二環式芳香族複素環式アミノ化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3133081A (en) *		1964-05-12		J-aminoindazole derivatives
US2971842A (en) *	1956-03-21	1961-02-14	Gen Aniline & Film Corp	Light sensitive layers for photomechanical reproduction
GB965511A (en) *	1961-11-30	1964-07-29	Smith Kline French Lab	Improvements in or relating to 3-aminoindazole derivatives
DE1280878B (de) *	1961-11-30	1968-10-24	Smith Kline French Lab	3-Aminoindazole
BE626284A (no) *	1962-04-28
DE1301319B (de) *	1965-09-08	1969-08-21	Siegfried Ag	3,5-Diaminoindazol, dessen Salze, sowie Verfahren zu deren Herstellung
US3720671A (en) *	1970-10-05	1973-03-13	Ciba Geigy Ag	Polycyclic dyestuffs
FR2111641A2 (en) *	1970-10-09	1972-06-09	Geigy Ag J R	Polycyclic cpds as dispersion dyestuffs for - hydrophobic organic fibres
DE2458965C3 (de) *	1974-12-13	1979-10-11	Bayer Ag, 5090 Leverkusen	3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
JPS51143010A (en) *	1975-06-04	1976-12-09	Kao Corp	Stable bleaching detergent composition
SU742430A1 (ru) *	1978-11-09	1980-06-25	Предприятие П/Я А-7850	Способ получени 3-амино-5-нитроиндазола
JPS58159473A (ja) *	1982-03-17	1983-09-21	Asahi Chem Ind Co Ltd	ベンゼン環置換基を有する新規な１位置換インダゾ−ル誘導体およびその製造法
DE3381617D1 (de) *	1982-03-17	1990-07-05	Asahi Chemical Ind	Indazol-derivate.
KR940021073A (ko) *	1993-03-02	1994-10-17	미야베 요시가즈	알쯔하이머병의 예방 또는 치료제, 그 스크리닝 방법 및 인간 유래의 타우 단백질 키나아제 i
KR100423899B1 (ko) *	2000-05-10	2004-03-24	주식회사 엘지생명과학	세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸

2002
- 2002-03-11 FR FR0202997A patent/FR2836915B1/fr not_active Expired - Fee Related
2003
- 2003-02-28 PA PA20038568301A patent/PA8568301A1/es unknown
- 2003-03-03 SV SV2003001494A patent/SV2003001494A/es not_active Application Discontinuation
- 2003-03-06 JO JO200323A patent/JO2326B1/en active
- 2003-03-06 TW TW092104839A patent/TWI329103B/zh not_active IP Right Cessation
- 2003-03-07 NZ NZ535147A patent/NZ535147A/en not_active IP Right Cessation
- 2003-03-07 AU AU2003242809A patent/AU2003242809B8/en not_active Ceased
- 2003-03-07 RS YU79504A patent/RS52396B/sr unknown
- 2003-03-07 CN CNA038053667A patent/CN1656078A/zh active Pending
- 2003-03-07 MX MXPA04007478A patent/MXPA04007478A/es active IP Right Grant
- 2003-03-07 CA CA2478542A patent/CA2478542C/fr not_active Expired - Fee Related
- 2003-03-07 ME MEP-2008-161A patent/ME00058B/me unknown
- 2003-03-07 BR BR0308373-0A patent/BR0308373A/pt not_active IP Right Cessation
- 2003-03-07 EP EP03744396.7A patent/EP1487804B1/fr not_active Expired - Lifetime
- 2003-03-07 PL PL03370478A patent/PL370478A1/xx unknown
- 2003-03-07 HR HRP20040824AA patent/HRP20040824B1/hr not_active IP Right Cessation
- 2003-03-07 WO PCT/FR2003/000752 patent/WO2003078403A2/fr not_active Ceased
- 2003-03-07 IL IL16383103A patent/IL163831A0/xx unknown
- 2003-03-07 JP JP2003576409A patent/JP4648630B2/ja not_active Expired - Fee Related
- 2003-03-07 PE PE2003000234A patent/PE20040155A1/es not_active Application Discontinuation
- 2003-03-07 ME MEP-161/08A patent/MEP16108A/xx unknown
- 2003-03-07 CN CN2010102771547A patent/CN101962365A/zh active Pending
- 2003-03-07 RU RU2004129780/04A patent/RU2345070C2/ru not_active IP Right Cessation
- 2003-03-07 KR KR1020047014199A patent/KR101068770B1/ko not_active Expired - Fee Related
- 2003-03-10 AR ARP030100808A patent/AR038915A1/es unknown
- 2003-03-11 US US10/385,871 patent/US6949579B2/en not_active Expired - Lifetime
- 2003-03-11 UY UY27713A patent/UY27713A1/es unknown
- 2003-03-11 MY MYPI20030839A patent/MY138269A/en unknown
- 2003-03-11 GT GT200300057A patent/GT200300057A/es unknown
2004
- 2004-08-05 MA MA27814A patent/MA27230A1/fr unknown
- 2004-08-23 ZA ZA2004/06687A patent/ZA200406687B/en unknown
- 2004-08-31 IL IL163831A patent/IL163831A/en not_active IP Right Cessation
- 2004-09-29 NO NO20044137A patent/NO329384B1/no not_active IP Right Cessation
2010
- 2010-04-06 JP JP2010087830A patent/JP5315287B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ535147A (en)	2007-08-31
RS52396B (sr)	2013-02-28
RU2004129780A (ru)	2005-04-10
FR2836915A1 (fr)	2003-09-12
MXPA04007478A (es)	2004-11-10
PL370478A1 (en)	2005-05-30
CN1656078A (zh)	2005-08-17
WO2003078403A2 (fr)	2003-09-25
MA27230A1 (fr)	2005-02-01
SV2003001494A (es)	2003-07-10
IL163831A (en)	2010-12-30
RS79504A (sr)	2006-12-15
RU2345070C2 (ru)	2009-01-27
AU2003242809A1 (en)	2003-09-29
FR2836915B1 (fr)	2008-01-11
CN101962365A (zh)	2011-02-02
IL163831A0 (en)	2005-12-18
KR20040091121A (ko)	2004-10-27
WO2003078403A3 (fr)	2004-04-22
PE20040155A1 (es)	2004-04-18
EP1487804A2 (fr)	2004-12-22
US20040014802A1 (en)	2004-01-22
HRP20040824A2 (en)	2005-06-30
TWI329103B (en)	2010-08-21
AR038915A1 (es)	2005-02-02
JP2010222357A (ja)	2010-10-07
JP2005530711A (ja)	2005-10-13
US6949579B2 (en)	2005-09-27
JP4648630B2 (ja)	2011-03-09
EP1487804B1 (fr)	2014-02-26
MY138269A (en)	2009-05-29
CA2478542A1 (fr)	2003-09-25
NO329384B1 (no)	2010-10-11
MEP16108A (en)	2010-06-10
BR0308373A (pt)	2005-01-11
TW200403226A (en)	2004-03-01
KR101068770B1 (ko)	2011-09-30
ZA200406687B (en)	2005-10-26
JP5315287B2 (ja)	2013-10-16
UY27713A1 (es)	2003-09-30
AU2003242809B8 (en)	2010-04-15
PA8568301A1 (es)	2005-02-04
GT200300057A (es)	2006-10-19
CA2478542C (fr)	2012-02-21
JO2326B1 (en)	2006-06-28
ME00058B (me)	2010-10-10
AU2003242809B2 (en)	2010-03-18
HRP20040824B1 (hr)	2013-05-31

Publication	Publication Date	Title
NO20044137L (no)	2004-11-25	Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter
DK1480955T3 (da)	2007-10-29	O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK1539712T3 (da)	2008-03-17	Pyrimidinderivater og deres anvendelse som CB2-modulatorer
DK1478629T3 (da)	2007-01-29	N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
DK1455785T3 (da)	2009-06-08	Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
DK1578755T3 (da)	2007-11-12	Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
DK1368349T3 (da)	2007-05-21	Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
ATE478870T1 (de)	2010-09-15	Spiroindolinpiperidinderivate
DK1556385T3 (da)	2010-06-14	Heterocyclocarboxamid-derivater
ATE450506T1 (de)	2009-12-15	Indol-3-schwefelderivate
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
DK1474408T3 (da)	2012-06-25	N-Phenyl-2-pyrimidinaminderivater
DK1701946T3 (da)	2008-04-28	1-piperazin- og 1-homopiperazincarboxylatderivater, deres fremstilling og deres terapeutiske anvendelse som inhibitorer af FAAH-enzymet
NO20034364D0 (no)	2003-09-29	Sapogenin-derivater, deres syntese og anvendelse samt metoder basert på deres anvendelse
DK1603915T3 (da)	2010-08-30	Substituerede 8-pyridinyl-dihydrospiro-cycloalkyl-pyrimido- 1,2-a-pyrimidin-6-on og 8-pyrimidinyl-dihydrospiro-cycloalkyl-pyrimido-1,2-a-pyrimidin-6-on-derivater og deres anvendelse mod neurogenerative sygdomme
DK1581518T3 (da)	2011-06-06	Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
NO20043580L (no)	2004-09-21	Quinazolinonderivater og deres bruk som CB agonister
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DE60307512D1 (de)	2006-09-21	3h-chinazoline -4-on derivaten
DK1525193T3 (da)	2008-04-28	Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
NO20052124D0 (no)	2005-04-29	Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
ATE423771T1 (de)	2009-03-15	Tetrahydrochinolinderivate
NL1024677A1 (nl)	2004-05-06	Therapeutische prolinederivaten.
DE602004007387D1 (de)	2007-08-16	5-substituierte chinazolinonderivate

Legal Events

Date	Code	Title	Description
2014-11-03	MM1K	Lapsed by not paying the annual fees